'Hope! Fight! Breathe!' offers latest updates in lung cancer research, treatments
Event Information (passed)
CINCINNATI—Lung cancer is the second most common cancer in the U.S. and is by far the leading cause of cancer death among both men and women, according to the American Cancer Society.
Each year, more people die of lung cancer than of colon, breast and prostate cancers combined.
While smoking is the leading cause of lung cancer, around 10 to 15 percent of people diagnosed with lung cancer have never smoked.
As a way to raise awareness of risks and to discuss the latest in lung cancer research, screening and treatment, the University of Cincinnati (UC) Cancer Institute Lung Cancer Center will host a community event Nov. 10, aimed at educating the public on these topics and more.
“This community-centered symposium, which is offered at no charge, will help to inform patients, their families and even just interested members of the general public about the ways we’re working to fight this disease locally at the UC Cancer Institute as well as a national level,” says Sandra Starnes, MD, co-director of the Lung Cancer Center, professor of surgery at the UC College of Medicine and UC Health thoracic surgeon.
The annual “Hope! Fight! Breathe!” symposium, being held from 8 a.m. to 1:30 p.m. Saturday, Nov. 10, at Courtyard by Marriott, 2813 Edwards Rd., by Rookwood Commons off of I-71, will update attendees on the latest in lung cancer screening, evaluation, treatment and survivorship as well as suggested nutrition and healthy living tips. The day’s activities will also include a patient speaker and a panel discussion with experts.
“This event offers a chance for attendees to come together to learn about this disease, network and offer support to one another,” adds John Morris, MD, co-director of the center, a member of the Cincinnati Cancer Center, professor in the Division of Hematology Oncology at the UC College of Medicine and a UC Health oncologist. “We’re excited for this opportunity to raise awareness about a cancer with such devastating impact and to show that progress that is being made right here in Cincinnati.”
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.